Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Incyte Corporation (INCY)
Incyte Corporation (INCY) News

INCY

Incyte (INCY)

Incyte Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INCY

<< Previous 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Next >>

Date	Time	Source	Headline	Symbol	Company
01/21/2022	4:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/20/2022	4:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/18/2022	8:00AM	Business Wire	Incyte to Report Fourth Quarter and Year-End 2021 Financial Results	NASDAQ:INCY	Incyte Corporation
01/18/2022	4:15AM	TipRanks	Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY) and Cytokinetics (CYTK)	NASDAQ:INCY	Incyte Corporation
01/14/2022	4:10PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INCY	Incyte Corporation
01/13/2022	1:45AM	TipRanks	Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Incyte (INCY) and InflaRx (IFRX)	NASDAQ:INCY	Incyte Corporation
01/06/2022	8:48PM	TipRanks	RBC Capital Remains a Hold on Incyte (INCY)	NASDAQ:INCY	Incyte Corporation
01/06/2022	4:29PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/06/2022	1:12AM	TipRanks	What Does Incyte’s Newly Added Risk Factor Reveal?	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:41PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:26PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:15PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/05/2022	4:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/04/2022	4:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/04/2022	4:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/04/2022	4:18PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/04/2022	4:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
01/04/2022	4:15PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
12/17/2021	6:30PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INCY	Incyte Corporation
12/16/2021	2:14AM	Business Wire	Incyte meldet Annahme und prioritäre Prüfung des sNDA-Antrags für Ruxolitinib-Creme (Opzelura™) als Behandlung für Patienten mit Vitiligo	NASDAQ:INCY	Incyte Corporation
12/15/2021	2:23PM	Business Wire	Incyte annonce que sa demande d’indication supplémentaire (sNDA) pour la crème au ruxolitinib (Opzelura™) a été acceptée et bénéficiera d’une évaluation prioritaire pour le traitement des patients atteints de vitiligo	NASDAQ:INCY	Incyte Corporation
12/15/2021	6:40AM	TipRanks	FDA Grants Incyte Priority Review for Ruxolitinib Cream	NASDAQ:INCY	Incyte Corporation
12/14/2021	4:30PM	Business Wire	Incyte Announces Acceptance and Priority Review of sNDA for Ruxolitinib Cream (Opzelura™) as a Treatment for Patients with Vitiligo	NASDAQ:INCY	Incyte Corporation
12/14/2021	8:00AM	Business Wire	Incyte to Present at Upcoming Investor Conferences	NASDAQ:INCY	Incyte Corporation
12/12/2021	8:08PM	Business Wire	Incyte: Aktualisierte Daten belegen schnelles und dauerhaftes Ansprechen auf Parsaclisib bei Patienten mit rezidivierten oder refraktären B-Zell-Non-Hodgkin-Lymphomen	NASDAQ:INCY	Incyte Corporation
12/11/2021	4:55PM	Business Wire	Incyte annonce des données mises à jour démontrant des réponses rapides et durables pour le parsaclisib chez des patients atteints de lymphome non hodgkinien à cellules B récidivant ou réfractaire	NASDAQ:INCY	Incyte Corporation

Showing the most relevant articles for your search:NASDAQ:INCY

<< Previous 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Next >>

Ethema Health (PK)

Asia Broadband (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

Anavex Life Sciences

Brookmount Explorations (PK)

RespireRx Pharmaceuticals (PK)

Virexit Technologies (PK)

Lightwave Logic

Rennova Health (PK)

SMC Entertainment (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock